Nervous system-spinal cord and spinal canal and epidural space, percutaneous approach
85814100
Level 3 · Class
Category
18 items in this category
- Exempt
85814103Introduction of analgesics, hypnotics, sedatives into epidural space, percutaneous approach - Exempt
85814111Introduction of anti-inflammatory into epidural space, percutaneous approach - Exempt
85814101Introduction of destructive agent into epidural space, percutaneous approach - Exempt
85814109Introduction of electrolytic and water balance substance into epidural space, percutaneous approach - Exempt
85814118Introduction of high-dose interleukin-2 into epidural space, percutaneous approach - Exempt
85814116Introduction of liquid brachytherapy radioisotope into epidural space, percutaneous approach - Exempt
85814108Introduction of local anesthetic into epidural space, percutaneous approach - Exempt
85814117Introduction of low-dose interleukin-2 into epidural space, percutaneous approach - Exempt
85814114Introduction of monoclonal antibody into epidural space, percutaneous approach - Exempt
85814110Introduction of nutritional substance into epidural space, percutaneous approach - Exempt
85814112Introduction of other anti-infective into epidural space, percutaneous approach - Exempt
85814115Introduction of other antineoplastic into epidural space, percutaneous approach - Exempt
85814104Introduction of other diagnostic substance into epidural space, percutaneous approach - Exempt
85814102Introduction of other gas into epidural space, percutaneous approach - Exempt
85814106Introduction of other therapeutic substance into epidural space, percutaneous approach - Exempt
85814113Introduction of oxazolidinones into epidural space, percutaneous approach - Exempt
85814105Introduction of radioactive substance into epidural space, percutaneous approach - Exempt
85814107Introduction of regional anesthetic into epidural space, percutaneous approach